We are live on ! Find out more

15 hedge funds and large institutions have $9.24M invested in BiomX in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

50% more funds holding

Funds holding: 1015 (+5)

18% more capital invested

Capital invested by funds: $7.81M → $9.24M (+$1.42M)

2.49% more ownership

Funds ownership: 0.18%2.66% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
15
Holders Change
+5
Holders Change %
+50%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
8
Increased
2
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

PHGE Hedge Fund Activity: Q3 2024 in Review

15 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q3 2024, worth a combined $9.24M — up 18% from $7.81M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PHGE positions and 3 closed out — a net gain of 5 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $3.3M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $7.66K sold.

  • 15 institutional investors held BiomX (PHGE) as of Q3 2024, up from 10 in Q2 2024.
  • Funds reported $9.24M of BiomX stock for Q3 2024, up 18% quarter-over-quarter.
  • 8 funds opened new BiomX positions in Q3 2024 and 3 closed out, a net change of +5 holders.
  • The largest BiomX buyer in Q3 2024 was Nantahala Capital Management, an estimated $3.3M added.
  • The largest BiomX seller in Q3 2024 was Renaissance Technologies, an estimated $7.66K sold.

Based on aggregated 13F filings for Q3 2024.